BioMed Research International / 2021 / Article / Tab 1 / Research Article
Preoperative Nutrition Support May Reduce the Prevalence of Postoperative Pancreatic Fistula after Open Pancreaticoduodenectomy in Patients with High Nutritional Risk Determined by NRS2002 Table 1 Basal data in preoperative nutrition support and no support groups in patients at high risk (
).Variable Preoperative nutrition support group ( ) No support group ( ) Age, mean (SD) (y) 60.2 (14.3) 63.8 (11.1) 0.117 Sex, male, (%) 22 (53.7) 46 (48.9) 0.614 BMI, mean (SD) (kg/m2 ) 22.8 (4.1) 23.7 (3.3) 0.169 History, (%) Diabetes 8 (19.5) 30 (31.9) 0.141 Hypertension 11 (26.8) 39 (41.5) 0.105 Coronary heart disease 4 (9.8) 10 (10.6) 0.877 Smoking 13 (31.7) 23 (24.5) 0.382 Drinking 12 (29.3) 18 (19.1) 0.193 Jaundice 24 (58.5) 44 (46.8) 0.210 Laboratory Albumin, mean (SD), (g/L) 38.5 (6.6) 37.9 (4.7) 0.572 White blood cell count, mean (SD) (×109 /L) 6.7 (3.4) 6.1 (2.7) 0.276 Haemoglobin, mean (SD) (g/L) 119.8 (18.0) 125.6 (17.0) 0.082 ALT, mean (SD) (U/L) 165.2 (163.7) 162.2 (157.1) 0.081 TBIL, mean (SD) (mg/dL) 120.6 (114.3) 87.4 (110.8) 0.116 AMY, mean (SD) (U/L) 77.1 (77.3) 66.0 (57.7) 0.550 Operation Operation duration, mean (SD) (min) 373.3 (92.7) 359.6 (114.6) 0.557 Intraoperative blood loss, mean (SD) (mL) 748.8 (766.1) 524.5 (560.3) 0.501 Intraoperative fluid infusion, mean (SD) (mL) 3406.1 (1416.4) 3658.6 (1727.9) 0.413 Diameter of main pancreatic duct, mean (SD) (mm) 3.3 (1.8) 3.0 (2.1) 0.577 Duct-to-mucous pancreaticojejunostomy, (%) 25 (61.0) 60 (63.8) 0.752 Hard pancreatic texture, (%) 21 (51.2) 38 (40.4) 0.245 Pancreatic duct stent, (%) 32 (78.0) 59 (62.8) 0.081 Pathology, (%) 0.530 Pancreatic duct adenocarcinoma 8 (19.5) 27 (28.7) Cholangiocarcinoma 12 (29.3) 26 (27.7) Ampullary carcinoma 9 (22.0) 14 (14.9) Duodenal carcinoma 3 (7.3) 7 (7.4) Other malignances 4 (9.8) 7 (7.4) Benign tumors 1 (2.4) 7 (7.4) Chronic pancreatitis 2 (4.8) 5 (5.3) Others 2 (4.8) 1 (1.1)